title: High-intensity chemotherapy and rituximab for the treatment of posttransplant lymphoproliferative disorder.
authors.affiliation: University of Colorado, Denver, Colorado 80262, USA. Robert.chen@uchsc.edu
authors.forename: Robert W
authors.initials: RW
authors.lastname: Chen
authors.forename: John W
authors.initials: JW
authors.lastname: Sweetenham
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D016031:Liver Transplantation / Q000009:adverse effects*; D008232:Lymphoproliferative Disorders / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab